Rising Pharma Holdings Inc. – Cetirizine Hydrochloride Tablets USP 5 mg

← Back to Drug Recalls

Recall Category: Drug Recalls

Date: 07/20/2026

Brand: Rising Pharma Holdings Inc.

Product: Cetirizine Hydrochloride Tablets USP 5 mg

Recall Reason: Potential cross contamination with Ranitidine

Company: Unique Pharmaceutical Laboratories

Dosage Form: Tablet

Recall Issue Type: Contamination / Sterility

View FDA Drug Recall Notice